XML 14 R3.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Accounts receivable, allowance $ (21,204) $ (21,647)
Deferred financing costs $ 9,908 $ 10,578
Common shares, par value (in USD per share) $ 0.01 $ 0.01
Common shares, shares authorized (in shares) 500,000,000 500,000,000
Common shares, shares issued (in shares) 284,034,111  
Common Stock    
Common shares, shares outstanding (in shares) 284,034,111 283,699,120